Emerging trends in the field of inflammation and proteinopathy in ALS/FTD spectrum disorder

F De Marchi, T Franjkic, P Schito, T Russo, J Nimac… - Biomedicines, 2023 - mdpi.com
Proteinopathy and neuroinflammation are two main hallmarks of neurodegenerative
diseases. They also represent rare common events in an exceptionally broad landscape of …

Chitinases as key virulence factors in microbial pathogens: understanding their role and potential as therapeutic targets

GJ Jeong, F Khan, N Tabassum, YM Kim - International Journal of …, 2023 - Elsevier
Chitinases are crucial for the survival of bacterial and fungal pathogens both during host
infection and outside the host in the environment. Chitinases facilitate adhesion onto host …

TDP-43 proteinopathy specific biomarker development

I Cordts, A Wachinger, C Scialo, P Lingor… - Cells, 2023 - mdpi.com
TDP-43 is the primary or secondary pathological hallmark of neurodegenerative diseases,
such as amyotrophic lateral sclerosis, half of frontotemporal dementia cases, and limbic age …

Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice

E Bertin, A Martinez, A Fayoux, K Carvalho… - Cellular and Molecular …, 2022 - Springer
Amyotrophic lateral sclerosis (ALS) is a fatal motoneuron (MN) disease characterized by
protein misfolding and aggregation leading to cellular degeneration. So far neither …

Inflammation in Metal-Induced Neurological Disorders and Neurodegenerative Diseases

R Wei, P Wei, H Yuan, X Yi, M Aschner… - Biological Trace Element …, 2024 - Springer
Essential metals play critical roles in maintaining human health as they participate in various
physiological activities. Nonetheless, both excessive accumulation and deficiency of these …

[HTML][HTML] Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis

L Donini, R Tanel, R Zuccarino, M Basso - Neuroscience Research, 2023 - Elsevier
Abstract Amyotrophic Lateral Sclerosis (ALS) is the most common motor neuron disease, still
incurable. The disease is highly heterogenous both genetically and phenotypically …

Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations

ML Rogers, DW Schultz, V Karnaros… - Brain …, 2023 - academic.oup.com
Amyotrophic lateral sclerosis is a relentless neurodegenerative disease that is mostly fatal
within 3–5 years and is diagnosed on evidence of progressive upper and lower motor …

Pathophysiological underpinnings of extra-motor neurodegeneration in amyotrophic lateral sclerosis: new insights from biomarker studies

D Reyes-Leiva, O Dols-Icardo, S Sirisi… - Frontiers in …, 2022 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) lie at
opposing ends of a clinical, genetic, and neuropathological continuum. In the last decade, it …

Chitinases, neuroinflammation and biomarkers in ALS

M Swash - Journal of Neurology, Neurosurgery & Psychiatry, 2020 - jnnp.bmj.com
CSF chitinase (Chit-1) and phosphorylated neurofilament heavy chain levels are both raised
in patients with amyotrophic lateral sclerosis (ALS), tweaking interest in these proteins as …

[PDF][PDF] BRAIN COMMUNICATIONS

JP Rogers, T Mastellari, AJ Berry, K Kumar, E Burchill… - 2023 - researchgate.net
Encephalitis lethargica: clinical features and aetiology Page 1 BRAIN COMMUNICATIONS
https://doi.org/10.1093/braincomms/fcae347 BRAIN COMMUNICATIONS 2024: fcae347 | 1 …